Medical/Pharmaceuticals
I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China
GAITHERSBURG, Md. and SHANGHAI, April 24, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the first patient in a Phase 3 registrational tri...
2023-04-24 21:00
1952
AITRICS to Participate in HIMSS USA 2023
* Introducing an AI Solution for predicting patient deterioration, 'VitalCare' * Second HIMSS USA Participation...Finding potential customers and establishing a foothold in the US market SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim, Jin-gyu Yoo), a company spe...
2023-04-24 21:00
1788
BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program
* Encouraging non-human primate (NHP) findings support the progression of IV-formulatedBMD-001 ahead of formal clinical studies for Alzheimer's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease * Further validation of Brain Targeting RNAi Nanomedicine (BTRiNTM), including target...
2023-04-24 20:00
1410
BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy
BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure. April is a crucial month to prioritize the respiratory hea...
2023-04-24 20:00
1888
DetectedX Launches MyImageDx Online Learning Platform for Radiology Educators at Association of University Radiologists and Society of Breast Imaging Meetings
Fully Customizable Interactive Learning Platform Enables Educators to Deliver Image-Based Learning using DetectedX's Award-Winning Online Training Technology and Tools SYDNEY, April 24, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today...
2023-04-24 20:00
1642
WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022
Revenue Up 5.8% Year-Over-Year to RMB8,964 Million Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 Million Diluted Earnings per Share (EPS) Up 35.8% Year-Over-Year to RMB0.72 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 14.1% Year-Over-...
2023-04-24 18:03
2396
Tibetan medicine advanced over past decade
BEIJING, April 24, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: Adhering to an equal emphasis on traditional Chinese and Western medicine, the government of the Tibet autonomous region has increased financial investment, formulated supportive policies and promoted the development of...
2023-04-24 17:04
1400
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes, in the International SCIE Journal
SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical's SGLT-2 inhibitor new drug, 'Envlo', have been internationally acknowledged. On April 4, Daewoong Pharmaceutical (CEO Seng-ho Jeon and Chang-jae Lee) announced that the efficacy and safety evalu...
2023-04-24 14:53
2397
Samsung Biologics Reports First Quarter 2023 Financial Results
* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. * Expected to maintain a strong growth trajectory with the full utilization of existing and newly expanded capacities. INCHEON, South Korea, April 24, 2023 /PRNews...
2023-04-24 14:51
2291
Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions
HANGZHOU, China, April 23, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. ("Hicicare"). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and ...
2023-04-24 10:36
1948
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...
2023-04-24 10:23
2471
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI
* The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed * The latest preclinical data explored the antitumor efficacy and the intracranial activity of BBT-207 SEONGNAM, South Korea and CAMBRIDGE, Mass., April 23, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ...
2023-04-24 10:00
1664
SCG Cell Therapy to Present Late-Breaking Data at the International Society for Cell & Gene Therapy (ISCT) Highlighting Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma
SINGAPORE, April 24, 2023 /PRNewswire/ -- Singapore based SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that late-breaking data from the company's TCR-T therapy pipeline...
2023-04-24 10:00
2331
Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform
LONDON, April 23, 2023 /PRNewswire/ -- On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical o...
2023-04-24 08:00
2652
Everest Medicines Launches Nefecon in China's Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy
SHANGHAI, April 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that Nefecon, the first-in-disease treatment fo...
2023-04-24 07:44
2726
For Earth Day 2023, Tianlong Champions the Safeguarding of Food Safety with Its Biolum Portable ATP Hygiene Monitoring System
XI'AN, China, April 21, 2023 /PRNewswire/ -- Tianlong
2023-04-21 20:43
16058
ITRI Took Home Three Edison Awards(TM) in 2023
HSINCHU, April 21, 2023 /PRNewswire/ -- The highly-anticipated 2023 Edison
Awards™
2023-04-21 19:27
3153
Nippon Express Group's MD Logistics Opens "Garner 2000 Pharmaceutical Logistics Center" in North Carolina, U.S.
TOKYO, April 21, 2023 /PRNewswire/ -- MD Logistics, LLC (hereinafter "MD"), a group company of NIPPON EXPRESS HOLDINGS, INC., held an opening ceremony on March 23 for the Garner 2000 Pharmaceutical Logistics Center, a dedicated pharmaceutical warehouse established inGarner in the U.S. state of Nor...
2023-04-21 14:00
3327
Jim Lim joins Zühlke Group as Head of Health & Medtech in Singapore
SINGAPORE, April 21, 2023 /PRNewswire/ -- Zühlke Group is pleased to announce the appointment ofJim Lim as Head of Market Unit (Health & Medtech) at Zühlke Asia. Based in Singapore, Jim will lead the organisation's regional efforts to serve the healthcare industry and continue to expand Zühlke's ...
2023-04-21 09:13
3194
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr.Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall c...
2023-04-21 09:06
2143
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Dhaka Court Dismisses Allegations Against Nagad Founder Tanvir A Mishuk
[Picked up by 289 media titles]
2024-12-16 18:32Internet celeb videos fuel Hainan travel popularity surge
[Picked up by 282 media titles]
2024-12-12 22:09
6th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
Macaronesian Stories, a moving campaign to rebuild a dream buried by La Palma's volcano in the Canary Islands
2024-12-13 22:46
5826
6th HIIFF Closes with Golden Coconut Award Ceremony
2024-12-11 22:19
5813
GoPaint Worldwide Creating Activity Lands at the HUAWEI Flagship Store Opéra in Paris
2024-12-13 23:52
5534
